(window.webpackJsonp=window.webpackJsonp||[]).push([[15],{334:function(i,a,e){"use strict";e.r(a);var t=e(7),l=Object(t.a)({},(function(){var i=this,a=i._self._c;return a("ContentSlotsDistributor",{attrs:{"slot-key":i.$parent.slotKey}},[a("h2",{attrs:{id:"_2000-the-hallmarks-of-cancer"}},[a("a",{staticClass:"header-anchor",attrs:{href:"#_2000-the-hallmarks-of-cancer"}},[i._v("#")]),i._v(" 2000 The hallmarks of cancer")]),i._v(" "),a("p",[i._v("main characters/capabilities of cancer")]),i._v(" "),a("ul",[a("li",[i._v("self-sufficiency in growth signals")]),i._v(" "),a("li",[i._v("limitless replicative potential")]),i._v(" "),a("li",[i._v("sustained angiogenesis")]),i._v(" "),a("li",[i._v("insensitivity to anti-growth signals")]),i._v(" "),a("li",[i._v("evading apoptosis")]),i._v(" "),a("li",[i._v("tissue invasion and metastasis")])]),i._v(" "),a("h2",{attrs:{id:"_2011-the-hallmarks-of-cancer-the-next-generation"}},[a("a",{staticClass:"header-anchor",attrs:{href:"#_2011-the-hallmarks-of-cancer-the-next-generation"}},[i._v("#")]),i._v(" 2011 The hallmarks of cancer : the next generation")]),i._v(" "),a("ul",[a("li",[i._v("the main characters of cancer\n"),a("ul",[a("li",[i._v("self-sufficiency in growth signals")]),i._v(" "),a("li",[i._v("limitless replicative potential")]),i._v(" "),a("li",[i._v("sustained angiogenesis")]),i._v(" "),a("li",[i._v("insensitivity to anti-growth signals")]),i._v(" "),a("li",[i._v("evading apoptosis")]),i._v(" "),a("li",[i._v("tissue invasion and metastasis")]),i._v(" "),a("li",[a("strong",[i._v("reprogramming of energy metabolism")])]),i._v(" "),a("li",[a("strong",[i._v("evading immune destruction")])])])])]),i._v(" "),a("p",[i._v("Figure 2. Intracellular Signaling Networks Regulate the Operations of the Cancer Cell")]),i._v(" "),a("p",[a("img",{attrs:{src:"https://s2.loli.net/2024/04/14/HtJDUBnKyEW9X3p.png",alt:"image.png|400"}})]),i._v(" "),a("h2",{attrs:{id:"_2022-hallmarks-of-cancer-new-dimensions"}},[a("a",{staticClass:"header-anchor",attrs:{href:"#_2022-hallmarks-of-cancer-new-dimensions"}},[i._v("#")]),i._v(" 2022 Hallmarks of Cancer : New Dimensions")]),i._v(" "),a("ul",[a("li",[i._v("Abstructure")]),i._v(" "),a("li",[i._v("Introduction")]),i._v(" "),a("li",[i._v("acquired hallmark capabilities\n"),a("ul",[a("li",[i._v("sustaining proliferative signaling")]),i._v(" "),a("li",[i._v("evading growth supressors")]),i._v(" "),a("li",[i._v("resisting cell death")]),i._v(" "),a("li",[i._v("enabling replicative immortality")]),i._v(" "),a("li",[i._v("inducing/accessing vasculature")]),i._v(" "),a("li",[i._v("activating invasion and metastasis")]),i._v(" "),a("li",[i._v("reprogramming cellular metabolism")]),i._v(" "),a("li",[i._v("avoinding immune destruction")])])]),i._v(" "),a("li",[i._v("enabling characteristics\n"),a("ul",[a("li",[i._v("genome instability & mutation")]),i._v(" "),a("li",[i._v("tumor-promoting inflammation")])])]),i._v(" "),a("li",[i._v("emerging halmarks & enabling characteristics\n"),a("ul",[a("li",[i._v("unlocking phenotypic plasticity")]),i._v(" "),a("li",[i._v("nonmutational epigenetic reprogramming")]),i._v(" "),a("li",[i._v("senescent cells")]),i._v(" "),a("li",[i._v("polymorphic microbiomes")]),i._v(" "),a("li",[i._v("unlocking phenotypic plasticity")])])])]),i._v(" "),a("p",[a("img",{attrs:{src:"https://s2.loli.net/2024/04/14/kneYHAUKSaNfwOb.png",alt:"image.png|800"}})]),i._v(" "),a("h2",{attrs:{id:"观点"}},[a("a",{staticClass:"header-anchor",attrs:{href:"#观点"}},[i._v("#")]),i._v(" 观点")]),i._v(" "),a("h3",{attrs:{id:"roadmap"}},[a("a",{staticClass:"header-anchor",attrs:{href:"#roadmap"}},[i._v("#")]),i._v(" roadmap")]),i._v(" "),a("p",[i._v("sequencing technology，model system yield unprecedented resolution of molecular cellular genomic level complexity of cancer")]),i._v(" "),a("p",[i._v("basic research & clinical practice")]),i._v(" "),a("ol",[a("li",[i._v("识别新弱点")]),i._v(" "),a("li",[i._v("免疫疗法进行精准医学")]),i._v(" "),a("li",[i._v("更深刻认识我微环境")]),i._v(" "),a("li",[i._v("利用新一代小鼠癌症模型")]),i._v(" "),a("li",[i._v("基因组指导下的精准医疗")]),i._v(" "),a("li",[i._v("理解肿瘤的起源")]),i._v(" "),a("li",[i._v("应对肿瘤转移")]),i._v(" "),a("li",[i._v("肿瘤和微生物")]),i._v(" "),a("li",[i._v("癌症代谢")]),i._v(" "),a("li",[i._v("回归到细胞水平研究癌症")])]),i._v(" "),a("h3",{attrs:{id:"big-question"}},[a("a",{staticClass:"header-anchor",attrs:{href:"#big-question"}},[i._v("#")]),i._v(" big question")]),i._v(" "),a("ol",[a("li",[i._v("性别相关免疫反应，生存情况")]),i._v(" "),a("li",[i._v("从根砍掉肿瘤")]),i._v(" "),a("li",[i._v("干掉肿瘤生态系统")]),i._v(" "),a("li",[i._v("全球范围内研究肿瘤（经济社会地位和肿瘤的关系）")]),i._v(" "),a("li",[i._v("开发高效的联合疗法（应对“慢性疾病”和耐药）")]),i._v(" "),a("li",[i._v("增强新抗原特异性的免疫反应")]),i._v(" "),a("li",[i._v("生物标志物，前提和生物样本")]),i._v(" "),a("li",[i._v("灌注肿瘤治疗中心血管效应")]),i._v(" "),a("li",[i._v("稀有癌症")])])])}),[],!1,null,null,null);a.default=l.exports}}]);